Skip to content

AMAZING PRAGUE (PRAGUE-12)

Surgical Treatment of Atrial Fibrillation - Prospective Randomized Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00665587
Acronym
AmP
Enrollment
220
Registered
2008-04-24
Start date
2007-06-30
Completion date
2012-06-30
Last updated
2008-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Post-Operative Complications, Restore of Sinus Rhythm

Keywords

Atrial fibrillation, Maze procedure, Mid-term results, Long-term results, Surgical ablation

Brief summary

Aim of the project is to assess the long-time clinical impact of surgical ablation (MAZE procedure) on patients who suffer from atrial fibrillation but are indicated to a cardiac surgery for other predominant cardiac diagnosis (heart valve surgery, coronary revascularization or combined surgery). In recent years, those patients are more and more frequently indicated to some type of MAZE procedure, without the real benefit of this procedure for patients has been assessed with an enough large, randomized study. Even though it is well known, that MAZE procedures declines the early postoperative incidence of atrial fibrillation, convincing data about its mid-term and long-term impact on patients and about the appearance of recidives of atrial fibrillation in long-time horizon are still missing. Our hypothesis assumes, that MAZE procedure will significantly decrease the appearance of atrial fibrillation one year after the operation, without increasing mortality or incidence of serious postoperative complications in thirty postoperative days.

Interventions

PROCEDURECox-MAZE III

Maze procedure according to standards of the department

Sponsors

Charles University, Czech Republic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* indication to a cardiac surgery (coronary bypass, valve repair, others or combination of those) * atrial fibrillation (paroxysmal, persistent or permanent) present or documented in last 6 month before the operation * signed informed consent

Exclusion criteria

* rejection of signing the informed consent with randomization * emergent surgery

Design outcomes

Primary

MeasureTime frame
presence of sinus rhythm1 year after surgery
death, myocardial infarction, vascular cerebral attack, renal failure with a need of haemodyalisis30 postoperative days

Secondary

MeasureTime frame
mortality, presence of sinus rhythm, serious complications- bleeding, vascular cerebral attack, heart failure, anticoagulation, anti-arrhytmics, pacemaker or ICD implantation, catether ablation...1,3,5 months 1,5 years after surgery

Countries

Czechia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026